ARCHIVES

Lenalidomide, An Altered Thalidomide, Shows Promise

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | November 24, 2006

Download PDF Visit The Full Archive

Related Articles

FDA Approves Kytril For Post-Operative Nausea

October 25, 2002

NCI Eases Some Cooperative Group Concern; DeVita Considers Other CCOP- Research Base Funding Option

April 2, 1982

NCI Receives 165 SBIR Grant Applications; Combines With Solid Contracts, No More Fiascos Are Expected

June 14, 1985

DCPC Board Backs Diet Fit Trial

October 20, 1989

BCDDP Follow Up To Cost $1.6 Million annually For Five Years Okayed; Limited To 59,000 Women

November 3, 1978

NCI-Approved Clinical Trials

June 25, 2004